| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |